Persistent Asset Partners »

Enlivex Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $81k 148k 0.55

More positions owned by Persistent Asset Partners

Intel Corporation Call Option (INTC)
Kla Corp Com New Call Option (KLAC)
Nebius Group Shs Class A Call Option (NBIS)
Kodiak Sciences Call Option (KOD)
Novo-nordisk A S Adr Put Option (NVO)
Corning Incorporated Call Option (GLW)
Vaxcyte Call Option (PCVX)
Micron Technology Call Option (MU)
Monte Rosa Therapeutics Call Option (GLUE)
Robinhood Mkts Com Cl A (HOOD)
Arcus Biosciences Incorporated Call Option (RCUS)
Stmicroelectronics N V Ny Registry (STM)
Uniqure Nv SHS Call Option (QURE)
Amphenol Corp Cl A (APH)
Marvell Technology Call Option (MRVL)

View all positions for Persistent Asset Partners

Top funds holding Enlivex Therapeutics

ARK Investment Management
Springbok Capital Management
Bank of America Corporation
Two Sigma Investments
Susquehanna International
Persistent Asset Partners
Renaissance Technologies
Geode Capital Management
Jpmorgan Chase & Co
Simplex Trading
Winton Capital
Morgan Stanley
Goldman Sachs Group
Citadel Advisors
UBS Group

View all funds holding Enlivex Therapeutics